We analysed the influence of the timing of surgery (< 48 hours, group 1, 21 patients vs > 48 hours, group 2, 14 patients) on the neurological outcome and restoration of mobility in 35 incomplete tetra-and paraplegic patients with metastatic spinal-cord compression.
Metastatic disease of the spine remains a challenging problem. Recent advances in methods of clinical diagnosis, imaging and chemo-and radiotherapy have led to improved outcomes in patients with cancer. [1] [2] [3] [4] Coincidental with improved palliative care during the last two decades has been the increase in bone metastases. 5 Most primary tumours which metastasise to the spine arise from the breast (39.3%), prostate (23.5%) and lung (19.9%) with a slight male predominance. 6, 7 The thoracic level with a prevalence of 70% in all patients with metastatic spinal disease, is followed by the lumbar (20%) and cervical (10%) spine. 8 Metastatic spinal-cord compression occurs in approximately 5% of all patients with cancer and requires emergency treatment because of the risks of vertebral collapse, spinal instability and further compression of the cord. 9 Without adequate and expeditious treatment the spinal cord is irreversibly damaged with the consequences of permanent or increasing sensorimotor deficits and bladder, bowel and cardiovascular dysfunction. [10] [11] [12] Although the pathways of metastatic and traumatic damage of the spinal cord are different, the possible consequences are complete immobility and the requirement for 24-hourly nursing care. 13 The onset of spinal symptoms is often non-specific, but the earliest and most common physical signs of metastatic spinal-cord compression are motor and sensory deficits followed subsequently by neurogenic bladder and bowel dysfunction.
14 There is some controversy as to the place of early surgical intervention in the management of metastatic spinal-cord compression. There have been some reports of improved neurology and quality of life after surgery in these patients even in a palliative situation. 5, 15 The importance of urgency to improve the prognosis and outcome is well known. 10 Improved mobility has been shown in patients with symptoms for less than 48 hours before surgery. 16 This retrospective clinical trial was designed therefore to assess further whether the timing of surgery in relation to the onset of pain and neurological symptoms influenced the outcome. Secondly, we investigated whether pre-operative mobility was a useful indicator of outcome after surgery.
Patients and Methods
All patients with metastatic spinal-cord compression undergoing surgery at the Orthopaedic University Hospital in Heidelberg between 2005 and 2006 were retrospectively reviewed. Those with a known or an unknown primary tumour, vertebral metastases, compression of the cord and a neurological deficit were included in the study. The presence of a neurogenic bladder or bowel dysfunction was also an inclusion criterion. Exclusion criteria were previous operation for vertebral metastases, brain metastases or other cognitive disorders, and other causes of a neurological deficit such as diabetes or stroke. The pain and neurological symptoms were classified using the American Spinal Injury Association impairment scale. 17 The patients were examined on three occasions, pre-operatively at admission (T0), post-operatively (T1) and at follow-up four to six weeks later (T2). This last period of time is the length of the basic rehabilitation programme in our institution for patients with metastatic spinal-cord compression. 18 A total of 35 patients was included, of whom 26 were able to walk with or without walking aids, five were wheelchairbound and four were bedridden. The diagnosis of the primary tumour had been known in 13 patients (37.1%) for less than one year, in 14 (40.0%) for one to five years and in eight (22.9%) for more than five years before the onset of metastatic spinal-cord compression. The primary site of the tumour is shown in Table I . The location and the number of vertebral metastases are shown in Tables II and III. Metastases involving more than two vertebrae were regarded as disseminated. At presentation the symptoms were of pain in 12 patients (34.2%), pain and sensory deficit in nine (25.7%), pain and motor deficit in one (2.9%), pain and neurological deficit in three (8.6%) and pain, neurological deficit and bladder and/or bowel dysfunction in ten (28.6%). Thus, although all patients had pain, 12 (34.2%) did not have neurological symptoms at presentation, but had some sensory and/or motor impairment on American Spinal Injury Association assessment.
Clinical and radiological data (radiographs, CT, MRI) were reviewed to obtain a Tokuhashi score 19, 20 and Harrington classification. 21 The latter assesses the acuteness of the onset of symptoms and 15 patients (42.9%) were classified as grade 5 with an acute onset and 20 (57.1%) as grade 3 with a more gradual onset.
Compression of the spinal cord in the cervical and thoracic area and of the thecal sac in the lumbar spine was present in all cases confirmed by MRI.
The patients were divided into two groups, those who were operated on within 48 hours of the development of symptoms (21, group 1) and those operated on more than 48 hours after the development of symptoms (14, group 2).
In group 2, three patients were operated on between 48 hours and one week and 11 more than one week after developing symptoms. Group 1 consisted of 15 men and six women with a mean age of 60 years (42 to 78) and a mean Tokuhashi score of 9 (5 to 13). A total of 12 patients (57.1%) were classified as grade 3 and nine (42.8%) as grade 5 on the Harrington classification.
Group 2 included four men and ten women with a mean age of 63 years (20 to 84) and a mean Tokuhashi score of eight (5 to 14). On the Harrington classification eight (57.1%) were grade 3 and six (42.9%) grade 5.
A comparison of the two groups regarding the level of compression of the spinal cord and the performed surgical approaches is shown in Table IV. A modified spinal cord injury measure (mSCIM) 22 (Table  V) , restricted to mobility and bladder function, was evaluated pre-(T0) and post-operatively (T1). The American Spinal Injury Association impairment scale was used to compare neurological status pre-and post-operatively (T01) and pre-operatively with follow-up (T02). Statistical analysis. This was performed using SPSS 15.0 version software (SPSS Inc., Chicago, Illinois). Differences between groups were analysed by the non-parametric chisquared and Mann-Whitney U tests. The level of significance was assigned at 5% because of the observational nature of the study.
Results
The pre-and post-operative (T01) American Spinal Injury Association impairment scale scores showed improvement in eight (38.1%) and no change in 13 patients (61.9%) in group 1 and in one (7.1%) with no change in ten (71.4%) and deteriorating in three (21.4%) in group 2 (p = 0.021, chi-squared test). When comparing the pre-operative scores with those at follow-up (T02), there was improvement in 15 (71.4%) and no change in six patients (28.6%) in A total of 26 of 35 patients (74.3%) were able to walk with or without aids pre-operatively and 29 (83%) were able to do so post-operatively (Table VI) . The number of patients who walked without aids doubled from seven (20.0%) pre-operatively to 14 (40.0%) post-operatively. In group 1 the number of patients who were mobile preoperatively increased from 17 (81%) to 19 (90%) whereas in group 2 it increased from nine (64%) to ten (71%). Deterioration of mobility occurred in four patients (19%) of group 1 and four patients (29%) of group 2.
Additionally, we found high rates in change in the American Spinal Injury Association impairment scale score in the group of 20 patients with normal bladder function preoperatively. There was improvement in nine (45%), no change in nine (45%) and deterioration in two (10%) compared with those with a dysfunctional bladder who had no change in 14 (93.3%) and deterioration in one (6.7%) (p = 0.003, chi-squared test). In a subgroup of 11 patients with normal bladder function who were operated on within 48 hours the American Spinal Injury Association impairment scale score improved in eight (72.7%) with no change in three (27.3%) compared with those who had a dysfunctional bladder who showed no changes in ten (100%) (p = 0.001, chi-squared test). All four patients in group 2 who showed an improved American Spinal Injury Association impairment scale score also had normal bladder function. Bowel function showed slight improvement in group 1, but this result was not statistically significant (p > 0.05, chi-squared test).
The mean hospital stay for all patients was 27 days (8 to 89). Complications occurring during hospital stay included wound infection (five patients, 14.3%), embolus (one patient, 2.9%), sepsis (one patient, 2.9%) and thrombosis (one patient, 2.9%).
Discussion
Our findings suggest that in patients with a neurological deficit due to metastatic spinal-cord compression, spinal decompression is more likely to be beneficial if undertaken within 48 hours of the development of symptoms. Other authors have also described the importance of this time interval. 16, 23, 24 The two endpoints of our study, neurological recovery and mobility, constitute two objective assessments of quality of life. 16 The patients in both groups were similar in regard to age, Tokuhashi Score, Harrington classification and level of spinal-cord lesion. All patients had pain, but 12 (34.2%) without neurological symptoms had sensorimotor abnormalities on American Spinal Injury Association impairment scale assesment at the time of presentation which underlines the importance of neurological examination. The standard operation for metastatic spinal-cord compression which is an oncological emergency remains rapid decompression with or without stabilisation. 25 The nature of the operations which were undertaken were similar in both groups. Our intention was not to show the superiority of a certain operative procedure under these circumstances. The surgical management of metastatic spinal disease without compression of the cord depends on the patient's disease and life expectancy. 26 If the patient is a candidate for surgery the intervention can be planned without pressure of time and will occasionally be curative. 27 The mean survival time after surgery for spinal metastatic disease is between 11 and 16 months. [28] [29] [30] Turgut et al 31 found, in a series of 70 patients with a solitary metastatic lesion, that surgery improved the patients' quality of life for their remaining short life span. Comparable pre-and post-operative findings were not, however, documented. We found that patients who were operated on within 48 hours had a higher potential for neurological improvement at six weeks (15 patients, 71.4%) and that there was no deterioration in six patients (28.6%). Most of our patients in group 1 were classified as American Spinal Injury Association D and 12 patients improved to American Spinal injury association E. It can be concluded that better pre-operative motor function will lead to a better outcome, as has previously been described. 15, 16, 32 Patients in group 2 maintained their neurological status (10 patients, 71.4%). All four patients in group 2 whose bladder function was normal had an improvement in the American Spinal Injury Association score.
Our results are in agreement with those of Harrington who described complete recovery in 42% and significant improvement in 26% of patients with major neurological impairment. 33 Thus, a poor prognosis is associated with surgery which is delayed by more than 48 hours, a low functional score pre-operatively, sensorimotor deficits, and bladder and sphincter dysfunction. If surgery was delayed (group 2) the outcome was equally poor in those patients whose neurological symptoms developed acutely or chronically.
The numbers of mobile patients in the delayed surgical group only increased from one (7%) pre-operatively to three (21%) post-operatively.
The weaknesses of our study are its retrospective design, the small sample sizes and the short follow-up. This time interval was chosen in order to exclude the development of other cancer-related symptoms. McLinton and Hutchison 10 reported a poor prognosis in patients with metastatic spinal-cord compression and death in 74% within three months of presentation. The neurological status is the strongest prognostic factor for mobility after treatment. 34 The neurological decline is time-dependent. 35 We can conclude that in patients with metastatic spinalcord compression the outcome of decompressive surgery with or without stabilisation is improved in those who undergo surgery within 48 hours of the development of symptoms. However, prospective studies with more patients are needed to clarify the prognosis of metastatic spinal-cord compression with regard to different anatomical regions.
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